141.
|
advanced glycosylation end products {AGEs} [bioch.] trafno¶æ: 6.5pkt.zaloguj siê |
142.
|
Committee for Proprietary Medicinal Products {CPMP} [og.] [med.] [farm.] trafno¶æ: 6.4pkt.zaloguj siê |
143.
|
receptors for advanced glycation end-products {RAGE} [bioch.] trafno¶æ: 6.4pkt.zaloguj siê |
144.
|
Receptor for Advanced Glycation End-Products {RAGE} [bioch.] [farm.] trafno¶æ: 6.4pkt.zaloguj siê |
145.
|
advanced therapy cell products {ATMP} [neur.] trafno¶æ: 6.4pkt.zaloguj siê |
146.
|
European Agency for the Evaluation of Medicinal Products {EMEA} [og.] [farm.] trafno¶æ: 6.3pkt.zaloguj siê |
147.
|
European Electrical Products Certification Association {EEPCA} [og.] trafno¶æ: 6.3pkt.zaloguj siê |
148.
|
Office for Registration of Medicinal Products, Medical Devices & Biocides [med.] [og.] trafno¶æ: 6.3pkt.zaloguj siê |
149.
|
Interaction with other medicinal products and other forms of interaction [med.] [farm.] trafno¶æ: 5.5pkt.zaloguj siê |
* Dok³adamy wszelkich starañ, aby wprowadzane przez nas has³a by³y poprawne. Jednak mimo weryfikacji, mog± pojawiæ siê b³êdy, za które wydawca nie bierze odpowiedzialno¶ci. Ka¿dy u¿ytkownik wykorzystuje has³a zawarte w s³owniku Verba Medica na w³asn± odpowiedzialno¶æ.